Premium
Waldenström macroglobulinemia terminating in acute leukemia: A report of three cases
Author(s) -
Horsman Douglas E.,
Card Robert T.,
Skinnider Leo F.
Publication year - 1983
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830150111
Subject(s) - pancytopenia , medicine , macroglobulinemia , chlorambucil , leukemia , cyclophosphamide , acute leukemia , multiple myeloma , waldenstrom macroglobulinemia , immunology , chemotherapy , bone marrow , lymphoma
Acute leukemia was observed to develop in three patients with Waldenstöm marcroglobulinemia. Each patient had been treated with cytotoxic drug therapy. Pancytopenia preceded the onset of the terminal leukemia in two of the three cases. The acute leukemias were all of acute myelogenous type. All of the patients died soon after the development of the terminal leukemia. A number of recent reports have documented acute terminal leukemia in patients with macroglobulinemias and multiple myeloma, as well as other malignant and nonmalignant diseases. The role of the cytotoxic drugs, especially chlorambucil, cyclophosphamide, and melhalan, in leukemogenesis has been raised by these recent reports.